Ayurvedic medicament classification: house mark or brand name alone does not make products patent or proprietary.

Ayurvedic medicines manufactured in accordance with authoritative texts and sold under the names specified in those texts remained classifiable as Ayurvedic medicaments under Tariff Heading 3003.31. The additional display of the manufacturer's house mark or brand name did not change their essential character or make them patent or proprietary medicaments, because Heading 3003.31 did not require exclusive absence of manufacturer identification. The residual heading 3003.39 applied only where the specific heading was inapplicable, so it could not displace the proper specific classification. The medicines were therefore correctly classified under Heading 3003.31 and entitled to exemption as Ayurvedic medicaments.

---

---

Issues: Whether Ayurvedic medicines manufactured in accordance with authoritative Ayurvedic texts and sold with the manufacturer's house mark or brand name were classifiable under Tariff Heading 3003.31 as Ayurvedic medicaments or under Tariff Heading 3003.39 as patent or proprietary medicaments.

Analysis: The medicines were manufactured according to the formulae described in authoritative Ayurvedic texts and the names of the medicines as found in those texts were reflected on the packs. The dispute centered on whether the additional display of the house name or brand name transformed the goods into proprietary medicines. Tariff Heading 3003.31 required manufacture in accordance with the prescribed formulae in authoritative books and sale under the name specified in such books. There was no requirement that the product be sold exclusively without any manufacturer identification. The presence of the house mark or brand name did not displace the essential character of the goods as Ayurvedic medicaments. The residual heading 3003.39 could be used only when the specific heading was inapplicable. The reasoning was supported by the distinction between house mark and product mark and the accepted view that manufacturer identification alone does not make an Ayurvedic medicine patent or proprietary.

Conclusion: The medicines were correctly classifiable under Tariff Heading 3003.31 and were entitled to exemption as Ayurvedic medicaments; classification under Tariff Heading 3003.39 was not sustainable.

Final Conclusion: The assessee succeeded on the classification issue, and the Revenue's challenge failed on the same reasoning.

Ratio Decidendi: For Ayurvedic medicaments, the use of a manufacturer's house mark or brand name does not by itself convert goods into patent or proprietary medicaments when the products are manufactured according to authoritative texts and sold under the names specified in those texts.

---